Akihiro Bessho

5PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 31, 2025
Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small Cell Lung Cancer Harboring EGFR Mutation.

Shintaro Kanda, Seiji Niho, Takayasu Kurata

|Jun 16, 2023
Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring EGFR mutation: an observational clinical study.

Saori Takata, Kei Morikawa, Hisashi Tanaka

|Dec 26, 2022
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis.

Hisashi Tanaka, Shigeru Tanzawa, Toshihiro Misumi

|Aug 18, 2022
A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630.

Yuri Taniguchi, Tsuneo Shimokawa, Yuichi Takiguchi

|Dec 18, 2021
A Randomized Phase II Study Comparing Nivolumab with Carboplatin-Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L).

Hidetoshi Hayashi, Shunichi Sugawara, Yasushi Fukuda

Pageof 1

Frequent Collaborators

2 joint publications

Satoru Miura

2 joint publications

Yosuke Kawashima

2 joint publications

Nobuyuki Yamamoto

1 joint publications

Hidetoshi Hayashi